NCT05642273View on ClinicalTrials.gov

The Effects of oXiris in Cardiogenic Shock Requiring VA-ECMO

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 25, 2022

Primary Completion Date

January 8, 2024

Study Completion Date

January 8, 2024

Conditions
Cardiogenic Shock
Interventions
DEVICE

oXiris membrane

oXiris membrane for 24h

DIAGNOSTIC_TEST

Blood tests

Blood tests just after randomization (0 h) and at 24 h, 48 h and 7 days

Trial Locations (1)

06351

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER